SVA 0.00% 2.2¢ simavita limited

Hmmm. Medline deal variation to non-exclusive a worry. Obviously...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 352 Posts.
    lightbulb Created with Sketch. 6
    Hmmm. Medline deal variation to non-exclusive a worry. Obviously it wasn't working. If Medline can't sell this stuff... how will Simavita go with a direct channel to market (competing head-on with Medline!)?

    The real question is "why couldn't Medline achieve sales success?". Either they couldn't convey the value to prospective customer targets (a problem) or they could convey the message, but there was insufficient perceived value in the product amongst these same customer targets (an even bigger problem).

    Tough road ahead IMO. Definitely a 'wait and see' proposition....because at the moment I don't see much.

    -RS
 
watchlist Created with Sketch. Add SVA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.